GSA Capital Partners LLP boosted its stake in shares of DocGo Inc. (NASDAQ:DCGO – Free Report) by 19.7% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 445,805 shares of the company’s stock after purchasing an additional 73,456 shares during the quarter. GSA Capital Partners LLP’s holdings in DocGo were worth $1,480,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds have also recently modified their holdings of the company. WCM Investment Management LLC boosted its holdings in shares of DocGo by 0.6% during the 3rd quarter. WCM Investment Management LLC now owns 2,626,971 shares of the company’s stock worth $8,879,000 after buying an additional 15,933 shares during the period. Harbor Capital Advisors Inc. boosted its holdings in shares of DocGo by 144.6% during the third quarter. Harbor Capital Advisors Inc. now owns 968,537 shares of the company’s stock worth $3,216,000 after acquiring an additional 572,522 shares during the period. P.A.W. Capital Corp grew its position in shares of DocGo by 1.9% in the third quarter. P.A.W. Capital Corp now owns 1,630,000 shares of the company’s stock valued at $5,412,000 after purchasing an additional 30,000 shares during the last quarter. SG Americas Securities LLC increased its stake in shares of DocGo by 97.5% during the third quarter. SG Americas Securities LLC now owns 38,147 shares of the company’s stock worth $127,000 after purchasing an additional 18,835 shares during the period. Finally, Point72 Asset Management L.P. lifted its holdings in DocGo by 1,655.7% during the 2nd quarter. Point72 Asset Management L.P. now owns 116,844 shares of the company’s stock worth $361,000 after purchasing an additional 110,189 shares during the last quarter. 56.44% of the stock is currently owned by institutional investors and hedge funds.
Analysts Set New Price Targets
A number of research analysts have commented on DCGO shares. Needham & Company LLC reaffirmed a “buy” rating and issued a $7.00 price objective on shares of DocGo in a report on Thursday, August 8th. Cantor Fitzgerald restated an “overweight” rating and issued a $5.00 price target on shares of DocGo in a research note on Friday, September 20th. Five analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, DocGo has an average rating of “Buy” and a consensus price target of $6.10.
DocGo Price Performance
Shares of NASDAQ DCGO opened at $4.23 on Thursday. The business has a fifty day moving average price of $3.48 and a two-hundred day moving average price of $3.34. The stock has a market capitalization of $432.81 million, a PE ratio of 15.11, a P/E/G ratio of 3.82 and a beta of 0.89. DocGo Inc. has a fifty-two week low of $2.75 and a fifty-two week high of $6.31.
DocGo Profile
DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.
Further Reading
- Five stocks we like better than DocGo
- Which Wall Street Analysts are the Most Accurate?
- Rocket Lab is the Right Stock for the Right Time
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- SoundHound AI Will Advance By Triple Digits in 2025: Here’s Why
- The How and Why of Investing in Gold Stocks
- Celsius Holdings: Big Drop, Big Opportunity? Analysts Say Yes
Want to see what other hedge funds are holding DCGO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DocGo Inc. (NASDAQ:DCGO – Free Report).
Receive News & Ratings for DocGo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocGo and related companies with MarketBeat.com's FREE daily email newsletter.